PRTK Stock Ownership Activity
PARATEK PHARMACEUTICALS INC 13F holders
No value investing guru has made any change to the PARATEK PHARMACEUTICALS INC (PRTK) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying PRTK now?
According to the latest SEC filing(s) PARATEK PHARMACEUTICALS INC (PRTK) has not been purchased by any super investor.
To see more about who is investing in PARATEK PHARMACEUTICALS INC (PRTK), please go to the PRTK ownership page.
2020 Q2
(1 result)
Current price: $2.23
29.17%
Reported price*: $3.15
2020 Q1
(1 result)
Current price: $2.23
29.17%
Reported price*: $3.15
2019 Q4
(2 results)
Current price: $2.23
44.67%
AVG reported price*: $4.03
2019 Q1
(1 result)
Current price: $2.23
58.39%
Reported price*: $5.36
2018 Q4
(1 result)
Current price: $2.23
56.53%
Reported price*: $5.13
2018 Q3
(1 result)
Current price: $2.23
77.01%
Reported price*: $9.70
2018 Q2
(1 result)
Current price: $2.23
78.14%
Reported price*: $10.20
2018 Q1
(1 result)
Current price: $2.23
82.85%
Reported price*: $13.00
2017 Q2
(1 result)
Current price: $2.23
90.75%
Reported price*: $24.10
2016 Q2
(1 result)
Current price: $2.23
83.97%
Reported price*: $13.91
2015 Q2
(1 result)
Current price: $2.23
91.35%
Reported price*: $25.77
2014 Q4
(1 result)
Current price: $2.23
93.77%
Reported price*: $35.79
13 of 13
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.